LYON, France, January 31, 2022 -- EDAP TMS SA (EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced positive clinical results from the Endo-HIFU-R1 Phase 2 study ...

LYON, France, May 12, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced Ablatherm ® High Intensity Focused Ultrasound (HIFU) will be ...

LYON, France, February 1, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, announced today that it has completed enrollment in its Phase 3 study (Endo-HIFU-R2) ...

BIRMINGHAM, Ala., Dec. 23, 2021 /PRNewswire/ -- Vituro Health is pleased to announce the new partnership with Dr. Tristan Berry of Southwest Premier Urology in Tucson, Arizona. This will allow Dr.

CHI Memorial is now offering high-intensity focused ultrasound (HIFU), a treatment option for prostate cancer patients. "HIFU is a revolutionary procedure designed to treat prostate cancer with ...

After a rather convoluted trip along the regulatory pathway, Edap TMS SA (Lyon, France) received 510(k) clearance from the FDA to market the Ablatherm integrated imaging high-intensity focused ...

HIFU treatment failure is more likely when there is cancer involvement at the prostate base. PSMA PET/CT may improve lesion detection and patient selection for focal therapy. The locations of prostate ...